This inventor holds 46 USPTO granted patents, primarily in Heterocyclic Compounds. Top assignees: Boehringer Ingelheim Gmbh, Boehringer Ingelheim Kg, Boehringer Ingelheim (Canada) Ltd.. Active years: 1976-2001.
Location History:
- Ingelheim am Rhine, DE (1976)
- Ingelheim am Rhein, DE (1976 - 1979)
- Wiesbaden, DE (1993)
- Mainz-Kastel, DE (1978 - 2001)
Company Filing History:
34 out of 306Â 
9 out of 197Â 
1 out of 62Â 
Years Active: 1976-2001
Areas of Expertise:
Title: Anton Mentrup: A Pioneer of Innovation in Mainz-Kastel
Introduction: Anton Mentrup, a visionary inventor based in Mainz-Kastel, Germany, is renowned for his passion for innovation and his unwavering commitment to excellence. With an impressive portfolio of 45 patents, Mentrup continues to inspire the next generation of inventors and shape the future of technology.
Latest Patents: Among Mentrup's latest patents are groundbreaking inventions such as HSV primase inhibitors, which are compounds that exhibit activity against the HSV primase enzyme. Additionally, he has developed new quaternary ammonium compounds that are instrumental in the treatment of bronchospasm.
Career Highlights: Mentrup has made significant contributions to the field of innovation during his tenure at companies like Boehringer Ingelheim GmbH and Boehringer Ingelheim KG. His expertise and dedication to pushing the boundaries of technology have led to the successful development of numerous groundbreaking inventions.
Collaborations: Throughout his career, Mentrup has collaborated with esteemed colleagues such as Kurt Schromm and Ernst-Otto Renth. Together, they have worked tirelessly to bring revolutionary ideas to life and drive progress in the realm of technological advancement.
Conclusion: Anton Mentrup's remarkable journey as an inventor underscores his exceptional talent, tireless work ethic, and unwavering dedication to innovation. His pioneering spirit continues to inspire inventors worldwide and will undoubtedly leave a lasting impact on the future of technology.